Berkeley, California
United States
40
2024-04-11
The entities that hold a legal rights for patent applications filed by inventor Campisi Judith:
Judith Campisi from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor
#2 | 2022-07-21Biomarkers for detecting senescent cells
#3 | 2022-03-31TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MEDIATED BY SENESCENT ASTROCYTES USING SMALL MOLECULE SENOLYTIC AGENTS
#4 | 2021-06-10Treating liver disease by selectively eliminating senescent cells
#5 | 2021-06-10Treating cardiovascular disease by selectively eliminating senescent cells
#6 | 2021-02-04TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM NEUROLOGICAL TISSUE
#7 | 2020-11-26BIOMARKER FOR SENESCENT CELLS
#8 | 2020-01-30Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
#9 | 2019-11-14THERAPY FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED DISEASE USING AN MDM2 INHIBITOR
#10 | 2019-07-04PASSIVE VACCINE FOR ELIMINATION OF SENESCENT CELLS
#11 | 2019-01-24Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells
#12 | 2019-01-03Pharmaceutical Products and Drug Combinations for Treating Atherosclerosis by Stabilizing Atherosclerotic Plaques and Promoting Plaque Regression
#13 | 2018-10-25Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
#14 | 2018-09-13Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
#15 | 2018-08-23Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye
#16 | 2018-08-23Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen
#17 | 2018-07-12COMPOSITIONS AND METHODS FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS
#18 | 2018-05-24Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells
#19 | 2018-05-03Treatment of ophthalmic conditions by selectively removing senescent cells from the eye
#20 | 2018-04-19Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
#21 | 2017-12-07Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease
#22 | 2017-11-16Treatment of joint pain
#23 | 2017-08-10Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
#24 | 2017-07-27Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline
#25 | 2017-07-13Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population
#26 | 2017-07-13METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS
#27 | 2017-07-13Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells
#28 | 2017-05-04Inhibiting activity of senescent cells using a glucocorticoid
#29 | 2017-02-16Transgenic mouse for determining the role of senescent cells in cancer
#30 | 2017-02-02Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
#31 | 2016-11-24METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS
#32 | 2016-02-11Immunogenic compositions for inducing an immune response for elimination of senescent cells
#33 | 2014-11-13METHODS FOR IMPROVING MEDICAL THERAPIES
#34 | 2013-10-31TARGETING SENESCENT CELLS AND CANCER CELLS BY INTERFERENCE WITH JNK AND/OR FOXO4
#35 | 2013-10-31TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4
#36 | 2012-01-26gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
#37 | 2009-07-16and genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
#38 | 2008-09-30Id-1 and Id-2 genes and products as markers of epithelial cancer
#39 | 2006-11-23Method for sensitive measure of low level apoptosis in cells
#40 | 2006-10-19Id-1 and Id-2 genes and products as markers of epithelial cancer
509510 ⎘